-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Metastatic Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Metastatic Melanoma Drug Details: TGI-2 (NM1F) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Solid Tumor Drug Details: TGI-2 (NM1F) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Metastatic Colorectal Cancer Drug Details: TGI-2 (NM1F) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Metastatic Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Metastatic Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Metastatic Ovarian Cancer Drug Details: TGI-2 (NM1F) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TGI-2 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TGI-2 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TGI-2 in Triple-Negative Breast Cancer (TNBC) Drug Details: TGI-2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ritlecitinib in Sezary Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ritlecitinib in Sezary Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ritlecitinib in Sezary Syndrome Drug Details: Ritlecitinib (Litfulo) acts as an...
-
Analyst Opinions
NewOnline Gambling in Greater China – Patent and Company Insights, Key Trends and Challenges
Online Gambling in Greater China Report Overview In Greater China, the trends in online gambling patents showcase innovative advancements, particularly focusing on enhancing user experience through the integration of virtual reality (VR) and Internet of Things (IoT) technologies. Additionally, these patents aim to improve operational efficiency within lotteries while ensuring fair play and security through the implementation of blockchain technology and advanced ticketing systems. The ’Online Gambling in Greater China’ research report dives into the key patent trends and active...
-
Product Insights
Likelihood of Approval Analysis for Heterozygous familial hypercholesterolemia (heFH)
Overview How likely is it that the drugs in Heterozygous familial hypercholesterolemia (heFH) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Heterozygous familial hypercholesterolemia (heFH) Overview Heterozygous familial hypercholesterolemia (HeFH) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Spartalizumab in Esophageal Squamous Cell Carcinoma (ESCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Spartalizumab in Esophageal Squamous Cell Carcinoma (ESCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Spartalizumab in Esophageal Squamous Cell Carcinoma (ESCC) Drug...